Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Transparency Market
Research
Molecular Diagnostics Market - Europe Industry Analysis, Size, Share, Growth,
Trends and Fore...
Molecular Diagnostics Market
Transparency Market Research
2
According to a new market report published by Transparency Mar...
Molecular Diagnostics Market
Transparency Market Research
3
(HAI) testing, chlamydophila pneumonia testing, chlamydia trac...
Molecular Diagnostics Market
Transparency Market Research
4
 Transcription Mediated Amplification (TMA)
 Next Generation...
Molecular Diagnostics Market
Transparency Market Research
5
 Southern Europe
o Italy
o Spain
o Portugal
o Rest of Souther...
Molecular Diagnostics Market
Transparency Market Research
6
3.2.1. Rising prevalence of chronic and infectious diseases in...
Molecular Diagnostics Market
Transparency Market Research
7
3.14. Mergers & Acquisitions
4. Market Segmentation – By Techn...
Molecular Diagnostics Market
Transparency Market Research
8
5.7. Europe Molecular Diagnostics Market for Microbiology, 201...
Molecular Diagnostics Market
Transparency Market Research
9
8.11. Meridian Bioscience, Inc.
8.12. PerkinElmer, Inc.
8.13. ...
Upcoming SlideShare
Loading in …5
×

Europe Molecular Diagnostics Market to Reach US$4.2 bn by 2023, Adoption of Next Generation Sequencing Technologies Rapidly Rise

135 views

Published on

Molecular diagnostics primarily refers to the class of diagnostic tests that identifies nucleic acids or proteins at the molecular level. Molecular diagnostics has emerged as one of the fastest growing segments in in vitro diagnostics industry.

Read More: http://www.transparencymarketresearch.com/europe-molecular-diagnostics-market.html

Published in: Healthcare
  • Hello! Who wants to chat with me? Nu photos with me here http://bit.ly/helenswee
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

Europe Molecular Diagnostics Market to Reach US$4.2 bn by 2023, Adoption of Next Generation Sequencing Technologies Rapidly Rise

  1. 1. Transparency Market Research Molecular Diagnostics Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023 Europe Molecular Diagnostics Market to Reach US$4.2 bn by 2023, Adoption of Next Generation Sequencing Technologies Rapidly Rise Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com 118 Page ReportPublished Date 25-Feb-2016 Buy Now Request Sample Press Release
  2. 2. Molecular Diagnostics Market Transparency Market Research 2 According to a new market report published by Transparency Market Research “Molecular Diagnostics Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” the Europe molecular diagnostics market was valued at US$ 1.6 billion in 2014 and is estimated to reach US$ 4.2 billion by 2023 at a CAGR of 11.4% from 2015 to 2023. Browse Full Report with TOC: http://www.transparencymarketresearch.com/europe-molecular-diagnostics- market.html This report on the molecular diagnostics market studies the current and future prospects of the market in Europe. Growing incidences of chronic infectious diseases such as tuberculosis, HIV/AIDS, diarrhea, pneumonia, in addition to increasing geriatric population, and rising number of biotechnology companies is expected to accentuate the growth of molecular diagnostics market in Europe. The Europe molecular diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the Europe molecular diagnostics market with respect to market segments based on technology, application and their geographic analysis. Based on technology, the molecular diagnostics market in Europe has been segmented into seven major categories: polymerase chain reaction, hybridization (ISH AND FISH), mass spectrometry, transcription mediated amplification (TMA), next generation sequencing, biochips and microfluidics, others which includes nanotechnology and proteomics. Likewise, on the basis of application, the Europe molecular diagnostics market has been segmented into oncology, infectious disease testing, genomics, blood screening, women's health, microbiology, and prenatal and newborn screening. Infectious disease testing has been segmented into two major categories, namely, virology and bacteriology. Virology segment includes human immunodeficiency virus (HIV) testing, human parainfluenza virus (1, 2, 3, 4) testing, human respiratory syncytial virus (A, B) testing, human papillomavirus (HPV) testing, human rhinovirus A/B testing, hepatitis C virus (HCV) testing, and others which includes human adenovirus (A/B/C/D/E), influenza (A, B), etc. Bacteriology includes hospital acquired infection REPORT DESCRIPTION
  3. 3. Molecular Diagnostics Market Transparency Market Research 3 (HAI) testing, chlamydophila pneumonia testing, chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing, staphylococcus aureus testing (MRSA), and others which includes haemophilus influenza, mycoplasma pneumonia, etc. The market segments have been extensively analyzed based on usefulness, adoption, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The molecular diagnostics market report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year. A brief patient pool analysis by infectious disease, cancer and cardiovascular disease have also been discussed in the Europe molecular diagnostics report. Geographically, the molecular diagnostics market in Europe has been categorized into five major regions: Northern Europe, Eastern Europe, Western Europe, Southern Europe, and Rest of Europe. The market size and forecast for each of these regions has been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, ADL matrix, growth share matrix, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the Europe molecular diagnostics market. Current and future trends has also been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the Europe molecular diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V., Hologic, Inc., Cepheid, Inc., Siemens AG, Alere. Inc., BioMerieux, Bio-Rad Laboratories, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., and others. Request A Sample Of This Report: The Europe molecular diagnostics market is segmented as given below: Europe Molecular Diagnostics Market, by Technology  Polymerase Chain Reaction  Hybridization (ISH and FISH)  Mass Spectrometry
  4. 4. Molecular Diagnostics Market Transparency Market Research 4  Transcription Mediated Amplification (TMA)  Next Generation Sequencing  Biochips and Microfluidics  Others (Nanotechnology and Proteomic) Europe Molecular Diagnostics Market, by Application  Oncology  Infectious Disease Testing  Genomics  Blood Screening  Women's Health  Microbiology  Prenatal and Newborn Screening Europe Molecular Diagnostics Drugs Market, by Major Region and Countries  Northern Europe o Ireland o Norway o Sweden o United Kingdom o Rest of Northern Europe (Denmark, Finland)  Eastern Europe o Ukraine o Poland o Czech Republic o Russia o Rest of Eastern Europe (Hungary, Romania)  Western Europe o France o Germany o Austria o Rest of Western Europe (Netherlands, Belgium)
  5. 5. Molecular Diagnostics Market Transparency Market Research 5  Southern Europe o Italy o Spain o Portugal o Rest of Southern Europe (Greece, Switzerland)  Rest of Europe Browse Full Press Release @ http://www.transparencymarketresearch.com/pressrelease/europe-molecular- diagnostics-market.htm Preface 1.1. Report Description 1.2. Market Segmentation 1.3. Research Methodology 2. Executive Summary 2.1. Europe Molecular Diagnostics Market Revenue, 2013–2023 (US$ Mn) 2.2. Europe Molecular Diagnostics Market, by Technology, 2014 (US$ Mn) 2.3. Europe Molecular Diagnostics Market, by Application, 2014 (US$ Mn) 2.4. Europe Market Share by Major Region, 2014 and 2023 (Value %) 2.5. Europe Molecular Diagnostics Market Snapshot 3. Europe Molecular Diagnostics Market – Industry Analysis 3.1. Introduction 3.2. Drivers TABLE OF CONTENT
  6. 6. Molecular Diagnostics Market Transparency Market Research 6 3.2.1. Rising prevalence of chronic and infectious diseases in Europe 3.2.2. Increasing awareness and acceptance of companion diagnostics and personalized medicines 3.3. Restraints 3.3.1. Issues with reimbursement policies 3.4. Opportunities 3.4.1. Technological advancement to offer sustained growth opportunities 3.5. Porter’s Five Forces Analysis: Europe Molecular Diagnostics Market 3.6. Market Attractiveness Analysis – Europe Molecular Diagnostics Market, By Region 3.7. Market Attractiveness Analysis – Europe Molecular Diagnostics Market, By Technology 3.8. Market Attractiveness Analysis – Europe Molecular Diagnostics Market, By Application 3.9. Patient Pool Analysis, by Infectious Diseases 3.10. Patient Pool Analysis, by Cancer 3.11. Patient Pool Analysis, by Cardiovascular Diseases 3.12. Company Market Share, Europe Molecular Diagnostics Market, By Key Players (2014) (%) 3.13. Competitive Landscape 3.13.1. ADL Matrix Analysis, 2014, by Top 3 Market Players 3.13.2. Brand Positioning Map, by Top 5 Market Players 3.13.3. Business Performance Analysis: F. Hoffmann-La Roche AG 3.13.4. Business Performance Analysis: Abbott Laboratories 3.13.5. Business Performance Analysis: QIAGEN 3.13.6. End-user Analysis (Growth Share Matrix)
  7. 7. Molecular Diagnostics Market Transparency Market Research 7 3.14. Mergers & Acquisitions 4. Market Segmentation – By Technology 4.1. Introduction 4.2. Europe Polymerase Chain Reaction in Molecular Diagnostics Market, 2013–2023 (US$ Mn) 4.3. Europe Hybridization (ISH and FISH) in Molecular Diagnostics Market, 2013–2023 (US$ Mn) 4.4. Europe Mass Spectrometry in Molecular Diagnostics Market, 2013–2023 (US$ Mn) 4.5. Europe Transcription Mediated Amplification (TMA) in Molecular Diagnostics Market, 2013–2023 (US$ Mn) 4.6. Europe Next Generation Sequencing in Molecular Diagnostics Market, 2013–2023 (US$ Mn) 4.7. Europe Biochips and Microfluidics in Molecular Diagnostics Market, 2013–2023 (US$ Mn) 4.8. Europe Other Technologies in Molecular Diagnostics Market, 2013–2023 (US$ Mn) 5. Market Segmentation – By Application 5.1. Introduction 5.2. Europe Molecular Diagnostics Market for Oncology, 2013–2023 (US$ Mn) 5.3. Europe Molecular Diagnostics Market for Infectious Disease Testing, 2013–2023 (US$ Mn) 5.3.1. Europe Molecular Diagnostics Market for Virology, 2013–2023 (US$ Mn) 5.3.2. Europe Molecular Diagnostics Market for Bacteriology, 2013–2023 (US$ Mn) 5.4. Europe Molecular Diagnostics Market for Genomics, 2013–2023 (US$ Mn) 5.5. Europe Molecular Diagnostics Market for Blood Screening, 2013–2023 (US$ Mn) 5.6. Europe Molecular Diagnostics Market for Women’s Health, 2013–2023 (US$ Mn)
  8. 8. Molecular Diagnostics Market Transparency Market Research 8 5.7. Europe Molecular Diagnostics Market for Microbiology, 2013–2023 (US$ Mn) 5.8. Europe Molecular Diagnostics Market for Prenatal and Newborn Screening, 2013–2023 (US$ Mn) 6. Europe Molecular Diagnostics Market - Regional Analysis 6.1. Northern Europe Molecular Diagnostics Market, 2013–2023 (US$ Mn) 6.2. Eastern Europe Molecular Diagnostics Market, 2013–2023 (US$ Mn) 6.3. Western Europe Molecular Diagnostics Market, 2013–2023 (US$ Mn) 6.4. Southern Europe Molecular Diagnostics Market, 2013–2023 (US$ Mn) 6.5. Rest of Europe Molecular Diagnostics Market, 2013–2023 (US$ Mn) 7. Current Trend and Historical Snapshot 8. Company Profiles 8.1. Abbott Laboratories 8.2. Agilent Technologies, Inc. 8.3. Alere, Inc. 8.4. Affymetrix, Inc. 8.5. bioMérieux SA 8.6. Bio-Rad Laboratories, Inc. 8.7. Cepheid, Inc. 8.8. Danaher Corporation 8.9. F. Hoffmann-La Roche Ltd. 8.10. Hologic, Inc.
  9. 9. Molecular Diagnostics Market Transparency Market Research 9 8.11. Meridian Bioscience, Inc. 8.12. PerkinElmer, Inc. 8.13. Randox Laboratories, Ltd. 8.14. QIAGEN N.V. 8.15. Siemens AG 8.16. Thermo Fisher Scientific, Inc. Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ About Us Contact

×